Home > Annual Financials > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES Financial Statement Analysis
[BOM: 540737]

The Revenues of SHREE GANESH REMEDIES have increased by 0.63% YoY .
The Earnings Per Share (EPS) of SHREE GANESH REMEDIES has decreased by -23.04 % YoY.
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Annual Financial Results
[BOM: 540737]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2020
Mar2019
Revenues ₹109 Cr₹109 Cr₹126 Cr₹64 Cr₹35 Cr
Expenses ₹74 Cr₹69 Cr₹84 Cr₹52 Cr₹27 Cr
Operating Profit (Excl OI) ₹35 Cr₹39 Cr₹42 Cr₹13 Cr₹8.74 Cr
Other Income ₹3.03 Cr₹3.73 Cr₹3.07 Cr₹3.91 Cr₹1.17 Cr
Interest ₹3.56 Cr₹2.11 Cr₹0.61 Cr₹0.54 Cr₹0.20 Cr
Depreciation ₹10 Cr₹9.57 Cr₹6.11 Cr₹2.30 Cr₹1.04 Cr
Profit Before Tax ₹24 Cr₹31 Cr₹38 Cr₹14 Cr₹8.67 Cr
Profit After Tax ₹18 Cr₹23 Cr₹28 Cr₹10 Cr₹6.24 Cr
Consolidated Net Profit ₹18 Cr₹23 Cr₹28 Cr₹10 Cr₹6.24 Cr
Earnings Per Share (Rs)₹13.83₹17.97₹21.89₹11.67₹6.95
PAT Margin (%)16.0620.7121.7316.3617.66
ROE(%)11.5317.2634.2227.5518.43
ROCE(%)14.6319.5337.8134.7925.66
Total Debt/Equity(x)0.190.260.300.110.02

Key Financials

Market Cap : ₹ 875.5 Cr
Revenue (TTM) : ₹ 99.0 Cr
Net Profit(TTM) : ₹ 15.4 Cr
EPS (TTM) : ₹ 12.1
P/E (TTM) : 56.7

Industry Peers & Returns1W1M1Y
SHREE GANESH REMEDIES 31.9% 9.9% 16.3%
SUN PHARMACEUTICAL INDUSTRIES 1.7% -1.4% 21.7%
DIVIS LABORATORIES 2% 10.3% 49.5%
TORRENT PHARMACEUTICALS -0.4% -0.5% 38.6%
CIPLA -0.5% -2.5% -10.2%
DR REDDYS LABORATORIES -1.2% 0% -7.1%
MANKIND PHARMA -1.5% -3.3% -4.6%
LUPIN -0.6% -9.4% 13%
ZYDUS LIFESCIENCES -3.2% 2.9% 19.2%


SHREE GANESH REMEDIES Revenues
[BOM: 540737]

Y-o-Y

0.63 %

5 Yr CAGR

32.63 %

Years Revenues % Change
Mar2026 ₹109 Cr
0.63
Mar2025 ₹109 Cr
-13.74
Mar2024 ₹126 Cr
96.65
Mar2020 ₹64 Cr
81.29
Mar2019 ₹35 Cr -


SHREE GANESH REMEDIES Operating Profit
[BOM: 540737]

Y-o-Y

-10.69 %

5 Yr CAGR

41.47 %

Years Operating Profit % Change
Mar2026 ₹35 Cr
-10.69
Mar2025 ₹39 Cr
-6.20
Mar2024 ₹42 Cr
233.99
Mar2020 ₹13 Cr
43.17
Mar2019 ₹8.74 Cr -

Operating Margins
Y-o-Y

-11.27 %

5 Yr CAGR

6.66 %

Years Operating Margin% % Change
Mar2026 32.04%
-11.27
Mar2025 36.11%
8.73
Mar2024 33.21%
69.87
Mar2020 19.55%
-21.04
Mar2019 24.76% -

SHREE GANESH REMEDIES Profit After Tax
[BOM: 540737]

Y-o-Y

-23.01 %

5 Yr CAGR

29.91 %

Years Profit After Tax % Change
Mar2026 ₹18 Cr
-23.01
Mar2025 ₹23 Cr
-17.93
Mar2024 ₹28 Cr
168.44
Mar2020 ₹10 Cr
67.94
Mar2019 ₹6.24 Cr -

PAT Margins
Y-o-Y

-22.45 %

5 Yr CAGR

-2.35 %

Years PAT Margin(%) % Change
Mar2026 16.06 %
-22.45
Mar2025 20.71 %
-4.69
Mar2024 21.73 %
32.82
Mar2020 16.36 %
-7.36
Mar2019 17.66 % -

SHREE GANESH REMEDIES Earnings Per Share (EPS)
[BOM: 540737]

Y-o-Y

-23.04 %

5 Yr CAGR

18.77 %

Years EPS % Change
Mar2026 ₹14
-23.04
Mar2025 ₹18
-17.91
Mar2024 ₹22
87.57
Mar2020 ₹12
67.91
Mar2019 ₹6.95 -

SHREE GANESH REMEDIES Return on Capital Employed (ROCE)
[BOM: 540737]

Y-o-Y

-25.09 %

5 Yr CAGR

-13.10 %

Years ROCE % Change
Mar2026 14.63%
-25.09
Mar2025 19.53%
-48.35
Mar2024 37.81%
8.68
Mar2020 34.79%
35.58
Mar2019 25.66% -

SHREE GANESH REMEDIES Share Price vs Sensex

Current Share Price : ₹684.0
Current MarketCap: ₹ 875.5 Cr
Updated EOD on :Sep 02,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

31.9%

9.9%

16.3%

SENSEX

-1%

-2.9%

-4.9%

SHREE GANESH REMEDIES related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE -0.3% 0.8% 17.1%
No NSE index found

You may also like the below Video Courses


FAQ about SHREE GANESH REMEDIES Financials


How the annual revenues of SHREE GANESH REMEDIES have changed ?

The Revenues of SHREE GANESH REMEDIES have increased by 0.63% YoY .

How the Earnings per Share (EPS) of SHREE GANESH REMEDIES have changed?

The Earnings Per Share (EPS) of SHREE GANESH REMEDIES has decreased by -23.04 % YoY .


Compare Stock Analytics of Peers of SHREE GANESH REMEDIES